- The New Money
- Posts
- Humanoid Robots Are Here, Green Ammonia, And Pfizer's New Research Collaboration
Humanoid Robots Are Here, Green Ammonia, And Pfizer's New Research Collaboration
Uncovering the world’s most exciting early stage companies. Discover what’s next.
The World’s Newest Humanoid Robot Is Here
Figure, an autonomous robotics startup with notable backers that include Nvidia and Microsoft, has officially launched their new humanoid robot known as Figure 02. The robot has a total of 6 cameras for scanning visual data, can carry up to 55 pounds, and is being touted by Figure as the ‘first ever commercially viable fully autonomous humanoid robot’.
Could Green Ammonia Change The Carbon Footprint Of Agriculture?
Ammonia is one of the most important chemical inputs for agricultural fertilizer, however the traditional production methods of the substance rely heavily on fossil fuels and produce significant carbon dioxide emissions. FuelPositive (TSXV: NHHH) is deploying an innovative solution, installing the world’s first decentralized modular green ammonia system at a farm in Manitoba, Canada. The system represents a significant breakthrough in the production of green ammonia being able to happen directly on-farm, and is capable of leveraging renewable energy sources for the production process.
Pfizer’s New Research Collaboration
Telescope Innovations (CSE: TELI) and pharmaceutical giant Pfizer (NYSE: PFE) have entered into a new research collaboration agreement that will focus on advancing new technologies in robotics and artificial intelligence for pharmaceuticals, chemistry and drug discovery.
The Sprint
Gryphon Digital (NASDAQ: GRYP) successfully mined Bitcoin worth approximately $1.34 million in the month of July, using carbon neutral power.
Arcadium Lithium (NYSE: ALTM) is acquiring technology and a pilot plant from Li-Metal (CSE: LIM) in a new deal for $11 million.
Trending Now
New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.
Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.